Status: Not yet recruiting
Oral Dexmedetomidine in Pediatric MRI
The objective of this preliminary study is to assess the utility of oral dexmedetomidine as the sole sedative agent in pediatric population undergoing MRI.
Participants needed: 18
Trial details
Phase: Phase 1Age: 3-6Biological sex: AllType: InterventionalSponsor: Soroush MerchantUpdated: Jun 25, 2026Locations: 1
Eligibility criteria
Participants 3-6 years old, male and female, all races and ethnicities [+1]
Refusal to take oral dexmedetomidine [+14]